Pharmacogenomics aims to tailor treatment to the patient. It opens the door to assessing a person's genetic make-up and using this information to make informed decisions, including the likelihood of treatment being effective from the outset. Pharmacogenomics is expected to bring many benefits to patients and the healthcare industry, increasing the number of new drugs and reducing the costs of drug development.